Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focus on amisulpride.

Ben Green1

  • 1University of Liverpool, UK. ben@priory.com

Current Medical Research and Opinion
|July 4, 2002
PubMed
Summary
This summary is machine-generated.

Amisulpride, a second-generation antipsychotic, effectively treats positive and negative schizophrenia symptoms. It shows a favorable safety profile compared to older antipsychotics and may offer antidepressant effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of positioning error in double displacement Talbot lithography.

Optics express·2025
Same author

Public perceptions of the Hippocratic Oath in the U.K. 2023.

BMC medical ethics·2024
Same author

Predictive Value of Physiological Values and Symptom Scores for Exacerbations in Bronchiectasis and Chronic Obstructive Pulmonary Disease With Frequent Exacerbations: Longitudinal Observational Cohort Study.

Interactive journal of medical research·2024
Same author

Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study.

The clinical respiratory journal·2024
Same author

UK research priority setting for childhood neurological conditions.

Developmental medicine and child neurology·2024
Same author

Successful introgression of wMel Wolbachia into Aedes aegypti populations in Fiji, Vanuatu and Kiribati.

PLoS neglected tropical diseases·2024

Area of Science:

  • Pharmacology
  • Psychiatry
  • Neuroscience

Background:

  • Amisulpride is a substituted benzamide and a second-generation antipsychotic.
  • Schizophrenia presents with positive and negative symptoms.
  • First-generation antipsychotics have notable side effects.

Purpose of the Study:

  • To evaluate the efficacy of Amisulpride in treating schizophrenia.
  • To assess the safety profile of Amisulpride.
  • To explore potential antidepressant effects of Amisulpride.

Main Methods:

  • Clinical studies comparing Amisulpride with first-generation antipsychotics.
  • Dose-ranging studies for Amisulpride in schizophrenia treatment.
  • Exploratory research into Amisulpride's effects on mood disorders.

Related Experiment Videos

Main Results:

  • Amisulpride is effective for both positive and negative symptoms of schizophrenia.
  • Recommended dosage ranges from 400 mg/day to 800 mg/day.
  • Amisulpride exhibits a good global safety profile, superior to haloperidol.

Conclusions:

  • Amisulpride is a valuable treatment option for schizophrenia.
  • Its safety profile makes it a preferable alternative to older antipsychotics.
  • Further research may elucidate Amisulpride's role in affective disorders and chronic fatigue syndrome.